Detection of selected fastidious bacteria

Clinical Infectious Diseases

Volumn 30, Issue 1, 2000, Pages 166-173

  Doern, Gary V ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC SENSITIVITY; BACTERIUM CULTURE; BACTERIUM DETECTION; BARTONELLA; BORDETELLA; BORRELIA BURGDORFERI; BRUCELLA; DIAGNOSTIC PROCEDURE; FRANCISELLA TULARENSIS; IMMUNOCHEMISTRY; LABORATORY DIAGNOSIS; LEGIONELLA; PRIORITY JOURNAL; REVIEW;

BACTERIOLOGICAL TECHNIQUES; CULTURE MEDIA; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS;

EID: 0033983572     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/313586     Document Type: Review

References (106)

1. Stout J, Yu VL, Vikers RM, et al. Ubiquitousness of Legionella pneumophila in the water supply of a hospital with endemic Legionnaires' disease. N Engl J Med 1982; 306:466-8.
2. Muder RR, Yu VL. Legionnaires' disease and related pneumonias. In: Gorbach SL, Bartlett JG, Blacklow NR, eds. Infectious diseases. Philadelphia: WB Saunders, 1992:505-12.
3. Edelstein PH, Meyer RD, Finegold SM. Laboratory diagnosis of Legionnaires' disease. Am Rev Respir Dis 1980; 121:317-27.
4. Winn WD Jr, Pasculle AW. Laboratory diagnosis of infections caused by Legionella species. Clin Lab Med 1982; 2:343-69.
5. Zuravleff JJ, Yu VL, Shourard JW, Davis BK, Rihs JD. Diagnosis of Legionnaires' disease: an update of laboratory methods with new emphasis on isolation by culture. JAMA 1983; 250:1981-5.
6. Winn WC Jr. Legionnaires disease: historical perspective. Clin Microbiol Rev 1988; 1:60-81.
7. Feeley JC, Gorman GW, Weaver RE, Mackel DC, Smith HW. Primary isolation media for Legionnaires disease bacterium. J Clin Microbiol 1978; 8:320-5.
8. Feeley JC, Gibson RJ, Gorman GW, et al. Charcoal-yeast extract agar: primary isolation medium for Legionella pneumophila. J Clin Microbiol 1979; 10:437-41.
9. Pasculle AW, Feeley JC, Gibson RJ, et al. Pittsburgh pneumonia agent: direct isolation from human lung tissue. J Infect Dis 1980; 141:727-32.
10. Edelstein PH. Comparative study of selective media for isolation of Legionella pneumophila from potable water. J Clin Microbiol 1982; 16:697-9.
11. Pine L, Franzus MJ, Malcolm GB. Guanine is a growth factor for Legionella species. J Clin Microbiol 1986; 23:163-9.
12. Hoffman, PS, Pine L, Bell S. Production of superoxide and hydrogen peroxide in medium used to culture Legionella pneumophila: catalytic decomposition by charcoal. Appl Environ Microbiol 1983; 45:784-91.
13. Winn WC Jr. Legionella. In: Murray PA, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, eds. Manual of clinical microbiology. 6th ed. Washington, DC: American Society for Microbiology, 1995:533-44.
14. Tompkins LS, Roessler BJ, Redd SC, Markowitz LE, Cohen ML. Legionella prosthetic-valve endocarditis. N Engl J Med 1988; 318:530-5.
15. Reimer LG, Carroll KC. Role of the microbiology laboratory in the diagnosis of lower respiratory tract infections. Clin Infect Dis 1998; 26:742-8.
16. Taylor JP, Perdue JN. The changing epidemiology of human brucellosis in Texas, 1977-1986. Am J Epidemiol 1989; 130:160-5.
17. Chomel BB, DeBess EE, Mangiamele DM, et al. Changing trends in the epidemiology of human brucellosis in California from 1973 to 1992: a shift toward foodborne transmission. J Infect Dis 1994; 170:1216-23.
18. Young EJ. Brucella species. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and practice of infectious disease. 4th ed. New York: Churchill Livingstone, 1995:253-60.
19. Gotuzzo E, Carrillo C, Guerra J, Llosa L. An evaluation of diagnostic methods for brucellosis - the value of bone marrow culture. J Infect Dis 1986; 153:122-5.
20. Daugherty MP, Dolter J, Evans GC, et al. Processing of specimens for isolation of unusual organisms. Part 6. Brucella spp. In: Isenberg HD, ed. Clinical microbiology procedures handbook. Washington, DC: American Society for Microbiology, 1992: 1. 18.23 7.
21. Mayer NP, Holcomb LA. Brucella. In: Murray PA, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, eds. Manual of clinical microbiology. 6th ed. Washington, DC: American Society for Microbiology, 1995:549-55.
22. Doern GV, Davaro R, George M, Campognone P. Lack of requirement for prolonged incubation of Septi-Chek blood culture bottles in patients with bacteremia due to fastidious bacteria. Diagn Microbiol Infect Dis 1996; 24:141-4.
23. Yagupsky P, Peled N, Press J, Abu-Rashid M, Abramson O. Rapid detection of Brucella melitensis from blood cultures by a commercial system. Eur J Clin Microbiol Infect Dis 1997; 16:605-7.
24. Solomon HM, Jackson D. Rapid diagnosis of Brucella melitensis in blood: some operational characteristics of the BACT/Alert. J Clin Microbiol 1992; 30:222-4.
25. Navas E, Guerrero A, Cobo J, Loza E. Faster isolation of Brucella spp. from blood by Isolator compared with BACTEC NR. Diagn Microbiol Infect Dis 1993; 16:79-81.
26. Bannatyne RM, Jackson MC, Memish Z. Rapid diagnosis of Brucella bacteremia by using the BACTEC 9240 system. J Clin Microbiol 1997; 35:2673-4.
27. Yagupsky P, Peled N, Press J, Abramson O, Abu-Rashid M. Comparison of BACTEC 9240 Peds Plus medium and Isolator 1.5 microbial tube for detection of Brucella melitensis from blood cultures. J Clin Microbiol 1997; 35:1382-4.
28. Hopla CE. The ecology of tularemia. Adv Vet Sci Comp Med 1974; 18:25-53.
29. Stewart SJ. Francisella. In: Murray PA, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, eds. Manual of clinical microbiology. 6th ed. Washington, DC: American Society for Microbiology, 1995:545-8.
30. Penn RL. Francisella tularensis (tularemia). In: Mandell GL, Bennett JE, Dolin R, eds. Principles and practice of infectious diseases. 4th ed. New York: Churchill Livingstone, 1995:2060-8.
31. Bernard K, Tessier S, Winstanley J, Chang D, Borczyk A. Early recognition of atypical Francisella tularensis strains lacking a cysteine requirement. J Clin Microbiol 1994; 32:551-3.
32. Baker CN, Hollis DG, Thornsberry C. Antimicrobial susceptibility testing of Francisella tularensis with a modified Mueller-Hinton broth. J Clin Microbiol 1985; 22:212-5.
33. Clark WA, Hollis DG, Weaver RE, Riley P. Identification of unusual pathogenic gram-negative aerobic and facultatively anaerobic bacteria. US Department of Health and Human Services publication no. 017-023-00149. Washington, DC: US Government Printing Office, 1984:164-5.
34. Westerman EL, McDonald J. Tularemia pneumonia mimicking Legionnaires' disease: isolation of organism on CYE agar and successful treatment with erythromycin. South Med J 1983; 76:1169-70.
35. Taylor JP, Istre GR, McChesney TC, Satalowich FT, Parker RL, McFarland LM. Epidemiologic characteristics of human tularemia in the southwest-central states, 1981-1987. Am J Epidemiol 1991; 133:1032-8.
36. US Department of Health and Human Services. Biosafety in microbiological and biomedical laboratories. 2d ed. US Department of Health and Human Services publication no. 88-8395. Washington, DC: US Government Printing Office, 1988.
37. Provenza JM, Klotz SA, Penn RL. Isolation of Francisella tularensis from blood. J Clin Microbiol 1986; 24:453-5.
38. Centers for Disease Control. Tularemic pneumonia - Tennessee. MMWR Morb Mortal Wkly Rep 1983; 32:363-9.
39. Evans ME, Gregory DW, Schaffner W, McGee ZA. Tularemia: a 30-year experience with 88 cases. Medicine (Baltimore) 1985; 64:251-69.
40. Kaiser AB, Rieves D, Price AH, et al. Tularemia and rhabdomyolysis. JAMA 1985; 253:241-3.
41. Steere AC, Broderick TE, Malwista SE. Erythema chronicum migrans and Lyme arthritis: epidemiologic evidence for a tick vector. Am J Epidemiol 1978; 108:312.
42. Steere AC. Borrelia burgdorferi (Lyme disease, Lyme borreliosis). In: Mandell GL, Bennett JE, Dolin R, eds. Principles and practice of infectious diseases. 4th ed. New York: Churchill Livingstone, 1995:2143-55.
43. Barbour AG. Laboratory aspects of Lyme borreliosis. Clin Microbiol Rev 1988; 1:399-414.
44. Kelly R. Cultivation of Borrelia hermsii. Science 1971; 173:443.
45. Stoenner HG, Dodd T, Larsen C. Antigenic variation of Borrelia hermsii. J Exp Med 1982; 156:1297-311.
46. Barbour AG, Burgdorfer W, Hayes SF, Peter O, Aeschlimann A. Isolation of a cultivable spirochete from Ixodes ricinus ticks of Switzerland. Curr Microbiol 1983; 8:123-6.
47. Barbour AG. Isolation and cultivation of Lyme disease spirochetes. Yale J Biol Med 1984; 57:521-5.
48. Rawlings JA, Fournier PV, Teltow GA. Isolation of Borrelia spirochetes from patients in Texas. J Clin Microbiol 1987; 25:1148-50.
49. Pollack RJ, Telford SR III. Spielman A. Standardization of medium for culturing Lyme disease spirochetes. J Clin Microbiol 1993; 31;1251-5.
50. Callister SM, Case KL, Agger WA, Schell RF, Johnson RC, Ellingson JLE. Effects of bovine serum albumin on the ability of Barbour-Stoenner-Kelly medium to detect Borrelia burgdorferi. J Clin Microbiol 1990; 28:363-5.
51. Johnson SE, Klein GC, Schmid GP, Bowen GS, Feeley JC, Schulze T. Lyme disease: a selective medium for isolation of the suspected etiological agent, a spirochete. J Clin Microbiol 1984; 19:81-2.
52. Steere AC, Grodzicki RL, Kornblatt AN, et al. The spirochetal etiology of Lyme disease. N Engl J Med 1983; 308:733-40.
53. Burgdorfer WR, Lane RS, Barbour AG, Gresbrink RA, Anderson JR. The western black-legged tick, Ixodes pacificus: a vector of Borrelia burgdorferi. Am J Trop Med Hyg 1985; 34:925-30.
54. Burgdorfer W, Gage KL. Susceptibility of the hispid cotton rat (Sigmodon hispidus) to the Lyme disease spirochete (Borrelia burgdorferi). Am J Trop Med Hyg 1987; 37:624-8.
55. Steere AC, Grodzicki RL, Craft JE, Shrestra M, Kornblatt AN, Malawista SE. Recovery of Lyme disease spirochetes from patients. Yale J Biol Med 1984; 57:557-60.
56. Benach JL, Bosler EM, Hanrahan JP, et al. Spirochetes isolated from the blood of two patients with Lyme disease. N Engl J Med 1983; 308:740-2.
57. Berger BW, Kaplan MH, Rothenberg IR, Barbour AG. Isolation and characterization of the Lyme disease spirochete from the skin of patients with erythema chronicum migrans. J Am Acad Dermatol 1985; 13:444-9.
58. Preac-Mursic V, Wilske B, Schierz G, Pfister HW, Einhaupl K. Repeated isolation of spirochetes from the cerebrospinal fluid of a patient with meningoradiculitis Bannwart. Eur J Clin Microbiol 1984; 3:564-5.
59. Kauffmann AF, Weyant RS. Leptospiraceae. In: Murray PA, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, eds. Manual of clinical microbiology. 6th ed. Washington, DC: American Society for Microbiology, 1995:621-5.
60. Farrar WE. Leptospira species (leptospirosis). In: Mandell GL, Bennett JE, Dolin R, eds. Principles and practice of infectious disease. 4th ed. New York: Churchill Livingstone, 1995:2137-41.
61. Cole JR. Spirochetes. In: Carter GR, Cole JR, eds. Diagnostic procedures in veterinary bacteriology and mycology. 5th ed. New York: Academic Press, 1990:41-60.
62. Saubolle MA. Leptospirosis. In: Wentworth BB, ed. Diagnostic procedures for bacterial infections. 7th ed. Washington, DC: American Public Health Association, 1987:335-46.
63. Baron EJ, Peterson LR, Finegold SM, eds. Spirochetes and other spiral-shaped organisms. In: Bailey and Scott's diagnostic microbiology. 9th ed. St. Louis: Mosby, 1994:445-50.
64. Manca N, Verardi R, Colombrita D, Ravizzola G, Savoldi E, Turano A. A radiometric method for the rapid detection of Leptospira organisms. J Clin Microbiol 1986; 23:401-3.
65. Rule PL, Alexander AD. Gellan gum as a substitute for agar in leptospiral media. J Clin Microbiol 1986; 23:500-4.
66. Slater LN, Welch DF. Bartonella. In: Murray PA, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, eds. Manual of clinical microbiology. 6th ed. Washington, DC: American Society for Microbiology, 1995:690-5.
67. Daly JS, Worthington MG, Brenner DJ, et al. Rochalimaea elizabethae sp. nov. isolated from a patient with endocarditis. J Clin Microbiol 1993; 31:872-81.
68. Regnery RL, Anderson BE, Clarridge JE III, Rodriguez-Barradas MC, Jones DC, Carr JH. Characterization of a novel Rochalimaea species, R. henselae sp. nov., isolated from blood of a febrile, human immunodeficiency virus-positive patient. J Clin Microbiol 1992; 30:265-74.
69. Welch DF, Hensel DM, Pickett DA, San Joaquin VH, Robinson A, Slater LN. Bacteremia due to Rochalimaea henselae in a child: practical identification of isolates in the clinical laboratory. J Clin Microbiol 1993; 31:2381-6.
70. Welch DF, Pickett DA, Slater LN, Steigerwalt AG, Brenner DJ. Rochalimaea henselae sp. nov., a cause of septicemia, bacillary angiomatosis, and parenchymal bacillary peliosis. J Clin Microbiol 1992; 30:275-80.
71. Koehler JE, Quinn FD, Berger TG, LeBoit PE, Tappero JW. Isolation of Rochalimaea species from cutaneous and osseous lesions of bacillary angiomatosis. N Engl J Med 1992; 327:1625-32.
72. Reed J, Brigati DJ, Flynn SD, et al. Immunocytochemical identification of Rochalimaeae henselae in bacillary (epithelioid) angiomatosis, parenchymal bacillary peliosis, and persistent fever with bacteremia. Am J Surg Pathol 1992; 16:650-7.
73. Schwartzman WA. Infections due to Rochalimaea: the expanding clinical spectrum. Clin Infect Dis 1992; 15:893-902.
74. Slater LN, Welch DF, Min KW. Rochalimaea henselae causes bacillary angiomatosis and peliosis hepatitis. Arch Intern Med 1992; 152:602-6.
75. Wong MT, Thornton DC, Kennedy RC, Dolan MJ. A chemically defined liquid medium that supports primary isolation of Rochalimaea (Bartonella) henselae from blood and tissue specimens. J Clin Microbiol 1995; 33:742-4.
76. Larson AM, Dougherty MJ, Nowowiejski DJ, et al. Detection of Bartonella (Rochalimaea) quintana by routine acridine orange staining of broth blood cultures. J Clin Microbiol 1994; 32:1492-6.
77. Spach DH, Callis KP, Paauw DS, et al. Endocarditis caused by Rochalimaea quintana in a patient infected with human immunodeficiency virus. J Clin Microbiol 1993; 31:692-4.
78. Anderson B, Sims K, Regnery R, et al. Detection of Rochalimaea henselae DNA in specimens from cat scratch disease patients by PCR. J Clin Microbiol 1994; 32:942-8.
79. Centers for Disease Control and Prevention. Resurgence of pertussis - United States, 1993. MMWR Morb Mortal Wkly Rep 1993; 42:952-60.
80. Regan J. The laboratory diagnosis of whooping cough. Clin Microbiol Newsl 1980; 2:78-82.
81. Marcon MJ. Bordetella. In: Murray PA, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, eds. Manual of clinical microbiology. 6th ed. Washington, DC: American Society for Microbiology, 1995:566-73.
82. Freidman RL. Pertussis: the disease and new diagnostic methods. Clin Microbiol Rev 1988; 1:365-76.
83. Marcon MJ, Hamoudi AC, Cannon HJ, Hribar MM. Comparison of throat and nasopharyngeal swab specimens for culture diagnosis of Bordetella pertussis infection. J Clin Microbiol 1987; 25:1109-10.
84. Hallander HO, Reizenstein E, Renemar B, Rasmuson G, Mardin L, Olin P. Comparison of nasopharyngeal aspirates with swabs for culture of Bordetella pertussis. J Clin Microbiol 1993; 31:50-2.
85. Hoppe JE, Weib A. Recovery of Bordetella pertussis from four kinds of swabs. Eur J Clin Microbiol 1987; 6:203-5.
86. Ross PW, Cumming CG. Isolation of Bordetella pertussis from swabs. Br Med J 1981; 283:403-4.
87. Hoppe JE, Woerz S, Botzenhart K. Comparison of specimen transport systems for Bordetella pertussis. Eur J Clin Microbiol 1986; 5:671-3.
88. Hunter PR. Survival of Bordetella pertussis in transport media. J Clin Pathol 1986; 39:119-20.
89. Regan J, Lowe F. Enrichment medium for the isolation of Bordetella. J Clin Microbiol 1977; 6:303-9.
90. Gilligan P. Laboratory diagnosis of Bordetella pertussis infection. Clin Microbiol Newsl 1983; 5:115-7.
91. Hoppe JE. Methods for isolation of Bordetella pertussis from patients with whooping cough. Eur J Clin Microbiol Infect Dis 1988; 7:616-20.
92. Kurzynski TA, Boehm DM, Rott-Petri JA, Schell RF, Allison PE. Comparison of modified Bordet-Gengou and modified Regan-Lowe media for the isolation of Bordetella pertussis and Bordetella parapertussis. J Clin Microbiol 1988; 26:2661-3.
93. Morrill WE, Barbaree JM, Fields BS, Sanden GN, Martin WT. Effects of transport temperature and medium on recovery of Bordetella pertussis from nasopharyngeal swabs. J Clin Microbiol 1988; 26:1814-7.
94. Jones GL, Kendrick PL. Study of a blood-free medium for transport and growth of Bordetella pertussis. Health Lab Sci 1969; 6:40-5.
95. Stauffer LR, Brown DR, Sandstrom RD. Cephalexin-supplemented Jones-Kendrick charcoal agar for selective isolation of Bordetella pertussis: comparison with previously described media. J Clin Microbiol 1983; 17:60-2.
96. Sutcliffe EM, Abbott JD. Selective medium for the isolation of Bordetella pertussis and parapertussis. J Clin Pathol 1972; 25:732-3.
97. Aoyama T, Murase Y, Iwata T, Imaizumi A, Suzuki Y, Sato Y. Comparison of blood-free medium (cyclodextrin solid medium) with Bordet-Gengou medium for clinical isolation for Bordetella pertussis. J Clin Microbiol 1986; 23:1046-8.
98. Bordet J, Gengou O. Le microbe de la coqueluche. Ann Inst Pasteur (Paris) 1906; 20:731-41.
99. Mishulow L, Sharpe LS, Cohen L. Beef heart charcoal agar for the preparation of pertussis vaccine. Am J Public Health 1953; 43:1466-72.
100. Hoppe JE, Schwaderer J. Comparison of four charcoal media for the isolation of Bordetella pertussis. J Clin Microbiol 1989; 27:1097-8.
101. Hoppe JE, Schlagenhaur M. Comparison of three kinds of blood and two incubation atmospheres for cultivation of Bordetella pertussis on charcoal agar. J Clin Microbiol 1989; 27:2115-7.
102. Hoppe JE, Weiss A, Woerz S. Failure of charcoal-horse blood broth with cephalexin to significantly increase the rate of Bordetella isolation from clinical specimens. J Clin Microbiol 1988; 26:1248-9.
103. Halperin SA, Bortolussi R, Wort AJ. Evaluation of culture, immunofluorescence and serology for the diagnosis of pertussis. J Clin Microbiol 1989; 27:752-7.
104. Cruickshank R. A combined Scottish study. Diagnosis of whooping cough: comparison of serological tests with isolation of Bordetella pertussis. Br Med J 1970; 4:637-9.
105. Lewis FA, Gust ID, Bennet NK. On the aetiology of whooping cough. J Hyg (Lond) 1973; 71:139-44.
106. Lewis K, Saubolle MA, Tenover FC, Rudinsky MF, Barbour SD, Cherry JD. Pertussis caused by an erythromycin-resistant strain of Bordetella pertussis. Pediatr Infect Dis J 1995; 14:388-91.